Medication info
Creszet Tablet 10/5 mg (Ezetimibe, Rosuvastatin)

Creszet Tablet 10/5 mg (Ezetimibe, Rosuvastatin)

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›5.2mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Aliko Pharmaceutical Co., Ltd.
Appearance
Pink elongated film-coated tablet
Packaging
30 tablets/box [10 tablets/PTP×3]
Approval status
Active

MFDS item code 202004611 · Approved 2020.06.23 · Insurance code 656005550

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
This medicine is administered once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient’s baseline LDL-cholesterol level, the recommended treatment target, and the patient’s response. Primary hypercholesterolemia The dosage range for this medicine is 10/5mg∼10/20mg once daily. The recommended initial dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL-cholesterol. After starting treatment with this medicine or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose should be adjusted accordingly. The dose may be increased to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a fixed-dose combination containing the same amount of each active ingredient) for convenience.

Ingredients

Manufacturer
Aliko Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL-cholesterol
  • elevated Apo B protein
  • elevated triglycerides
  • elevated non-HDL-cholesterol
  • increased risk of atherogenic vascular disease
View approved original text

This medication helps improve blood cholesterol and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia. It is particularly used to lower total cholesterol, LDL-cholesterol, Apo B, triglycerides, and non-HDL-cholesterol while increasing HDL-cholesterol levels. This medication should be administered alongside a dietary regimen when dietary changes and other lifestyle improvements alone are insufficient. It plays an important role in reducing the risk of atherogenic vascular diseases due to hypercholesterolemia. Before administration, it is necessary to identify and treat other causes of dyslipidemia, such as diabetes and hypothyroidism, and regular lipid testing should be conducted to monitor therapy outcomes. In summary, this medication effectively improves cholesterol and lipid levels, contributing to the prevention of cardiovascular diseases.

How to take

Adult dose

This medicine is administered once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient’s baseline LDL-cholesterol level, the recommended treatment target, and the patient’s response. Primary hypercholesterolemia The dosage range for this medicine is 10/5mg∼10/20mg once daily. The recommended initial dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL-cholesterol. After starting treatment with this medicine or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose should be adjusted accordingly. The dose may be increased to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a fixed-dose combination containing the same amount of each active ingredient) for convenience.

Precautions

This medication can affect muscles and may result in muscle pain, muscle weakness, or in severe cases, rhabdomyolysis. Patients who experience serious muscle issues or who are at high risk for muscle damage due to acute infections, hypotension, major surgery, etc., should temporarily halt or discontinue use of this medication. Patients allergic to ingredients in this medication, those with active liver disease, patients with unexplained persistent liver enzyme elevations, those with muscle diseases, patients with severe kidney impairment, pregnant women or women who may become pregnant, and nursing mothers should not take this medication. Additionally, patients with kidney or liver problems, those with a history of alcoholism, hypothyroidism, elderly patients, or those with a history of certain genetic muscle disorders should use this medication with caution and consult a physician immediately if muscle-related symptoms develop. During the course of taking this medication, regular liver function tests and muscle enzyme tests should be performed, and patients should inform their healthcare providers immediately if muscle pain, muscle cramps, malaise, or fever occurs. If there are signs of worsening liver function or severe liver damage, medication should be discontinued. This medication can interact with other drugs, so patients must inform healthcare providers about current medications, especially when taking certain antibiotics, antifungals, immunosuppressives, anticoagulants, or fibrate class drugs, as caution is needed in these cases. Pregnant or nursing women should not take this medication, and women of childbearing age should use appropriate contraceptive methods during treatment. This medication has not been adequately evaluated for effectiveness or safety in children and adolescents, therefore it is not recommended. Elderly patients are at higher risk of myopathy, so caution is advised during use, and dizziness may occur when driving or operating machinery, so patients should be careful. In cases of overdose, since there is no specific antidote, appropriate treatment and supportive therapy based on symptoms are needed, including monitoring liver function and muscle enzyme levels. Lastly, this medication should be kept out of reach of children, and transferring it to another container could alter its quality, so caution is advised.

Side effects

nasopharyngitis, indigestion, elevated ALT, edema, myalgia, elevated AST, headache, acute pyelonephritis, dry mouth, elevated liver enzymes, abnormal liver function tests, increased serum lactate dehydrogenase, pruritus, upper respiratory infection, elevated blood sugar, increased serum CPK, elevated liver enzymes, chest discomfort, dizziness, drowsiness, neurodegenerative disorders, orthostatic dizziness, migraine, diabetes, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, fatty liver, liver impairment, hepatic toxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased serum alkaline phosphatase, irregular heart rate, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory dysfunction, pelvic pain, breast cysts, eyelid drooping, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, chest pain, facial edema, strange sensation, drug intolerance, irritable bowel syndrome, esophagitis, colorectal polyps, thrombocytopenia, polyneuropathy, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, sleep disturbances, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, memory decline, forgetfulness, amnesia, memory disturbances, confusion, myasthenia gravis, oculomotor myasthenia, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myopathy, myositis, rhabdomyolysis, weakness, fatigue, numbness, paresthesia, chest discomfort, anorexia, abdominal distension, syncope, systemic pain, muscle cramps, gout, erectile dysfunction, thrombocytopenia, increased serum creatinine, elevated blood pressure, increased blood urea, upper abdominal pain, vomiting, gastritis, dry mouth, epigastric discomfort, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, urticaria, hyperhidrosis, rash, pruritus, upper respiratory infection, conjunctival hyperemia, renal failure, liver dysfunction, increased serum creatinine, elevated blood pressure, increased blood urea, increased CPK, abnormal liver function tests

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, and it is recommended to keep it at room temperature between 1 to 30 degrees Celsius. This storage method helps maintain the drug's effectiveness and safety.

Appearance and packaging

Appearance

Pink elongated film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP×3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.